Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Refractory anemia with ring sideroblasts"'
Autor:
Darci Zblewski, Mark R. Litzow, Ayalew Tefferi, Mrinal S. Patnaik, Aref Al-Kali, Beth R. Larrabee, Kebede H. Begna, Naseema Gangat, William J. Hogan, Ronald S. Go, James M. Foran, Michelle A. Elliott
Publikováno v:
Mayo Clinic Proceedings. 94:1467-1474
To study the changes in overall outcome of patients with myelodysplastic syndromes (MDSs) after approval of several treatments.We identified 54,953 MDS cases in the National Cancer Data Base diagnosed from January 1, 2004, through December 31, 2013,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed91adc199c322baa35b98224fb7a13b
https://doi.org/10.1016/j.mayocp.2019.02.029
https://doi.org/10.1016/j.mayocp.2019.02.029
Autor:
Xiaoyi Wang, Jan Philipp Bewersdorf, Nikolai A. Podoltsev, Chi Zhang, Xiaomei Ma, Amer M. Zeidan, Rong Wang, Scott F. Huntington, Steven D. Gore
Publikováno v:
Leukemialymphoma. 62(10)
Existing studies regarding the role of DNA methyltransferase inhibitors (DNMTi) and lenalidomide in refractory anemia with ring sideroblasts (RARS) are limited. Using the surveillance, epidemiology, and end results-medicare database, we assembled a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6e2dfd1dcdc92dbf2bc8567b75f6c5
https://pubmed.ncbi.nlm.nih.gov/33899659
https://pubmed.ncbi.nlm.nih.gov/33899659
Autor:
Markus Rechsteiner, Rudolf Benz, Markus G. Manz, Corinne C Widmer, Kathrin Zimmermann, Stefan Balabanov
Publikováno v:
Leukemialymphoma. 61(10)
The provisional diagnosis refractory anemia with ring sideroblasts and thrombocytosis was recognized in the WHO 2016 revision of the hematologic neoplasm as a distinct entity and was renamed myelod...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904f5744843a7d87def9a831b58e66d6
https://pubmed.ncbi.nlm.nih.gov/32449412
https://pubmed.ncbi.nlm.nih.gov/32449412
Publikováno v:
Clin Lymphoma Myeloma Leuk
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are hybrid group of chronic myeloid neoplasms combining features of both MDS and MPN. The World Health Organization classification coined this group designation in 2008 to include chronic myelomo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e020537170d6b8ebe3dd1c9e7376afb
https://doi.org/10.1016/j.clml.2018.11.019
https://doi.org/10.1016/j.clml.2018.11.019
Publikováno v:
Leukemia research. 94
Background Anabolic steroids, such as danazol, have been used for years in the treatment of myelodysplastic syndromes (MDS). Their successful use has been documented in aplastic anemia, hypoplastic MDS, and immune thrombocytopenia, among other hemato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1102619e7168682425514e230eb6f445
https://pubmed.ncbi.nlm.nih.gov/32470869
https://pubmed.ncbi.nlm.nih.gov/32470869
Autor:
Yosuke Ogata, Hiroko Iizuka, Yuka Harada, Norio Komatsu, Noriko Doki, Masao Hagihara, Kazuteru Ohashi, Naoki Shingai, Hironori Harada
Publikováno v:
International Journal of Hematology. 108:598-606
Splicing factor gene mutations are found in 60-70% of patients with myelodysplastic syndromes (MDS). We investigated the effects of splicing factor gene mutations on the diagnosis, patient characteristics, and prognosis of MDS. A total of 106 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecbf4998a8d5a1bda22faa5057019f2
https://doi.org/10.1007/s12185-018-2551-y
https://doi.org/10.1007/s12185-018-2551-y
Autor:
Marcin W. Wlodarski, Christian P. Kratz, Charlotte M. Niemeyer, Kathrin Thomay, Brigitte Schlegelberger, Mwe Mwe Chao, Victor B Pastor, Detlev Schindler, Gudrun Goehring
Publikováno v:
Klinische Pädiatrie. 229:329-334
Individuals with Fanconi anemia (FA) have a high risk of developing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), yet the secondary somatic mutations lending to these malignancies remain to be further elucidated. We employed a next
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7d80d1ebd043ec8aef116e73990bac
https://doi.org/10.1055/s-0043-117046
https://doi.org/10.1055/s-0043-117046
Publikováno v:
Tropical Journal of Pathology and Microbiology. 3:67-70
Refractory anemia with ring sideroblasts and thrombocytosis (RARS - T) is a rare disease with a controversial status which presents a diagnostic dilemma as it shows overlapping clinical, laboratory and morphological features of two distinct entities-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71799f45fe299b1705f928cacb75e961
https://doi.org/10.17511/jopm.2017.i01.12
https://doi.org/10.17511/jopm.2017.i01.12
Autor:
Irene Luna, Mariam Ibáñez, Mar Tormo, José Cervera, Blanca Navarro, Ivan Martin, Laia Pedrola, Esperanza Such, Eva Villamón, Silvestre Oltra, Ana Vicente, Guillermo Sanz, Inés Gómez-Seguí, Miguel A. Sanz, María López-Pavía
Publikováno v:
Leukemia & Lymphoma. 58:1686-1693
The incidence of SF3B1 mutations in patients with RARS is high. Recently, it has been shown that SF3B1 and DNMT3A mutations overlap more often than expected, although it is not clear how this could affect the disease. We studied SF3B1 and DNMT3A in 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f50a7f27f4ebf5891e1935a77974dc27
https://doi.org/10.1080/10428194.2016.1246725
https://doi.org/10.1080/10428194.2016.1246725
Autor:
Chetasi Talati, Eric Padron
Publikováno v:
Current Hematologic Malignancy Reports. 11:425-433
According to the recently published 2016 World Health Organization (WHO) classification of myeloid malignancies, myelodysplastic/myeloproliferative neoplasms (MDS/MPN) include atypical chronic myeloid leukemia (aCML), MDS/MPN-unclassifiable (MDS/MPN-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2a60745aa0b4e6103b846902c8518e
https://doi.org/10.1007/s11899-016-0350-1
https://doi.org/10.1007/s11899-016-0350-1